208 related articles for article (PubMed ID: 29996667)
1. Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Scher AI; Wang SJ; Katsarava Z; Buse DC; Fanning KM; Adams AM; Lipton RB
Cephalalgia; 2019 Feb; 39(2):296-305. PubMed ID: 29996667
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
[TBL] [Abstract][Full Text] [Related]
3. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Lipton RB; Seng EK; Chu MK; Reed ML; Fanning KM; Adams AM; Buse DC
Headache; 2020 Sep; 60(8):1683-1696. PubMed ID: 33448374
[TBL] [Abstract][Full Text] [Related]
5. Migraine progression in subgroups of migraine based on comorbidities: Results of the CaMEO Study.
Lipton RB; Fanning KM; Buse DC; Martin VT; Hohaia LB; Adams AM; Reed ML; Goadsby PJ
Neurology; 2019 Dec; 93(24):e2224-e2236. PubMed ID: 31690685
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
[TBL] [Abstract][Full Text] [Related]
7. Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Lipton RB; Fanning KM; Buse DC; Martin VT; Reed ML; Manack Adams A; Goadsby PJ
Headache; 2018 Jul; 58(7):933-947. PubMed ID: 30024028
[TBL] [Abstract][Full Text] [Related]
8. Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study.
Buse DC; Powers SW; Gelfand AA; VanderPluym JH; Fanning KM; Reed ML; Adams AM; Lipton RB
Headache; 2018 Apr; 58(4):512-524. PubMed ID: 29355924
[TBL] [Abstract][Full Text] [Related]
9. Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Dodick DW; Loder EW; Manack Adams A; Buse DC; Fanning KM; Reed ML; Lipton RB
Headache; 2016 May; 56(5):821-834. PubMed ID: 27143127
[TBL] [Abstract][Full Text] [Related]
10. Allodynia in migraine: association with comorbid pain conditions.
Tietjen GE; Brandes JL; Peterlin BL; Eloff A; Dafer RM; Stein MR; Drexler E; Martin VT; Hutchinson S; Aurora SK; Recober A; Herial NA; Utley C; White L; Khuder SA
Headache; 2009 Oct; 49(9):1333-44. PubMed ID: 19788473
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Prevalence, Symptoms, Impact, and Psychiatric Comorbidities in Migraine and Probable Migraine: A Population-Based Study.
Song TJ; Cho SJ; Kim WJ; Yang KI; Yun CH; Chu MK
Headache; 2019 Feb; 59(2):215-223. PubMed ID: 30623976
[TBL] [Abstract][Full Text] [Related]
12. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
[TBL] [Abstract][Full Text] [Related]
13. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
[TBL] [Abstract][Full Text] [Related]
14. Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design.
Serrano D; Lipton RB; Scher AI; Reed ML; Stewart WBF; Adams AM; Buse DC
J Headache Pain; 2017 Oct; 18(1):101. PubMed ID: 28980171
[TBL] [Abstract][Full Text] [Related]
15. Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Buse DC; Fanning KM; Reed ML; Murray S; Dumas PK; Adams AM; Lipton RB
Headache; 2019 Sep; 59(8):1286-1299. PubMed ID: 31407321
[TBL] [Abstract][Full Text] [Related]
16. The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results.
Adams AM; Serrano D; Buse DC; Reed ML; Marske V; Fanning KM; Lipton RB
Cephalalgia; 2015 Jun; 35(7):563-78. PubMed ID: 25304766
[TBL] [Abstract][Full Text] [Related]
17. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.
Lipton RB; Serrano D; Holland S; Fanning KM; Reed ML; Buse DC
Headache; 2013 Jan; 53(1):81-92. PubMed ID: 23078241
[TBL] [Abstract][Full Text] [Related]
18. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results.
Reed ML; Fanning KM; Serrano D; Buse DC; Lipton RB
Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study.
Hutchinson S; Lipton RB; Ailani J; Reed ML; Fanning KM; Adams AM; Buse DC
Mayo Clin Proc; 2020 Apr; 95(4):709-718. PubMed ID: 32247344
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with triptan use in episodic migraine: results from the American Migraine Prevalence and Prevention Study.
Chu MK; Buse DC; Bigal ME; Serrano D; Lipton RB
Headache; 2012 Feb; 52(2):213-23. PubMed ID: 22413150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]